Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1

被引：6
|
作者：
Thomas, S. [1 ,2 ]
Laino, A. [1 ,2 ]
Sturm, R. [1 ]
Nufer, K. [1 ]
Lambie, D. [2 ,3 ]
Shepherd, B. [2 ]
Atkinson, V. [4 ]
Adams, L. [1 ]
Soyer, H. P. [1 ,2 ]
Schaider, H. [1 ]
机构：
[1] Univ Queensland, Translat Res Inst, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia
[2] Princess Alexandra Hosp, Dept Dermatol, Brisbane, Qld, Australia
[3] IQ Pathol, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 05期
关键词：
MALIGNANT-MELANOMA; MANAGEMENT; COHORT;
D O I：
10.1111/jdv.14678
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E176 / E177
页数：2
相关论文
共 50 条
  • [21] Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason
    Gajewski, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [22] Limited-duration anti-PD-1 therapy for patients with metastatic melanoma
    Makela, Siru
    Kohtamaki, Laura
    Laukka, Marjut
    Juteau, Susanna
    Hernberg, Micaela
    ACTA ONCOLOGICA, 2020, 59 (04) : 438 - 443
  • [23] Impact of age on toxicity in patients treated with anti-PD-1 therapy for melanoma
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Salem, Joe-Elie
    Balko, Justin
    Johnson, Douglas B.
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
    Diem, S.
    Kasenda, B.
    Spain, L.
    Martin-Liberal, J.
    Marconcini, R.
    Gore, M.
    Larkin, J.
    BRITISH JOURNAL OF CANCER, 2016, 114 (03) : 256 - 261
  • [25] Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
    S Diem
    B Kasenda
    L Spain
    J Martin-Liberal
    R Marconcini
    M Gore
    J Larkin
    British Journal of Cancer, 2016, 114 : 256 - 261
  • [26] Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
    Reddy, Swathi B.
    Possick, Jennifer D.
    Kluger, Harriet M.
    Galan, Anjela
    Han, Dale
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (08) : 307 - 311
  • [27] Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody
    Richtig, G.
    Ramelyte, E.
    Koch, L.
    Greinix, H.
    Ferrone, S.
    Dummer, R.
    Richtig, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (10) : E381 - E383
  • [28] Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
    Frantz Dupuis
    Laurence Lamant
    Emilie Gerard
    Nouritza Torossian
    Leonor Chaltiel
    Thomas Filleron
    Marie Beylot-Barry
    Caroline Dutriaux
    Sorilla Prey
    Audrey Gros
    Marie-Laure Jullie
    Nicolas Meyer
    Béatrice Vergier
    British Journal of Cancer, 2018, 119 : 193 - 199
  • [29] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).
    Lee, Jenny H. J.
    Cooper, Adam James
    Lyle, Megan Kate
    Liniker, Elizabeth
    Menzies, Alexander M.
    Kefford, Richard
    Long, Georgina V.
    Carlino, Matteo S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Dietary fish oil and aspirin to augment anti-PD-1 immunotherapy in metastatic melanoma
    Chacon, Alexander C.
    Qin, Shuyang S.
    Melucci, Alexa D.
    Jackson, Katherine M.
    Burchard, Paul R.
    Dave, Yatee A.
    Jewell, Rachel
    Belt, Brian A.
    Tabayoyong, William
    Linehan, David C.
    Prieto, Peter A.
    CANCER RESEARCH, 2022, 82 (12)
12345